These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines. Kouraklis G; Triche TJ; Wesley R; Tsokos M Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148 [TBL] [Abstract][Full Text] [Related]
8. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene. Schaaf G; Hamdi M; Zwijnenburg D; Lakeman A; Geerts D; Versteeg R; Kool M Cancer Res; 2010 Jan; 70(2):762-71. PubMed ID: 20068162 [TBL] [Abstract][Full Text] [Related]
9. Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array. Nishimura R; Takita J; Sato-Otsubo A; Kato M; Koh K; Hanada R; Tanaka Y; Kato K; Maeda D; Fukayama M; Sanada M; Hayashi Y; Ogawa S Cancer Sci; 2013 Jul; 104(7):856-64. PubMed ID: 23578105 [TBL] [Abstract][Full Text] [Related]
10. Distinct clonal evolution in a case with anaplastic embryonal rhabdomyosarcoma. Kato K; Yoshimi A; Noda A; Otani H; Hojo H; Tanaka M; Tanaka Y; Ito Y; Nishimura R; Takita J; Yanai T; Koike K; Tsuchida M Pediatr Int; 2021 Jul; 63(7):782-789. PubMed ID: 33021000 [TBL] [Abstract][Full Text] [Related]
12. FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma. Crose LE; Etheridge KT; Chen C; Belyea B; Talbot LJ; Bentley RC; Linardic CM Clin Cancer Res; 2012 Jul; 18(14):3780-90. PubMed ID: 22648271 [TBL] [Abstract][Full Text] [Related]
13. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488 [TBL] [Abstract][Full Text] [Related]
14. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326 [TBL] [Abstract][Full Text] [Related]
15. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence. Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744 [TBL] [Abstract][Full Text] [Related]
16. Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Shukla N; Ameur N; Yilmaz I; Nafa K; Lau CY; Marchetti A; Borsu L; Barr FG; Ladanyi M Clin Cancer Res; 2012 Feb; 18(3):748-57. PubMed ID: 22142829 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes. Püsküllüoglu M; Lukasiewicz E; Miekus K; Jarocha D; Majka M Folia Histochem Cytobiol; 2010 Dec; 48(4):671-7. PubMed ID: 21478114 [TBL] [Abstract][Full Text] [Related]
18. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440 [TBL] [Abstract][Full Text] [Related]
19. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype. Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058 [TBL] [Abstract][Full Text] [Related]
20. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]